Image 2-Zepzelca (lurbinectedin) - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Zepzelca (lurbinectedin) for the Treatment of Small Cell Lung Cancer

Image 2-Zepzelca (lurbinectedin)
Zepzelca (lurbinectedin) was approved by the FDA in June 2020. Credit: Shutterstock